(P-1428) Real-World Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine among Adults 65-74, 75-84, and ≥85 Years of Age in the United States

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Amanda C. Miles, MPH (she/her/hers)

Senior Manager, RWE Scientist, Vaccines
Pfizer
New York, NY, United States

Co-Author(s)

Lindsay Grant, PhD, MPH (she/her/hers)

Senior Director, Evidence Generation Strategist Pneumococcal Vaccines
Pfizer Inc.
Collegeville, PA, United States
JV

Jelena Vojicic, MD

Vaccines Medical Lead
Pfizer Canada
Kirkland, QC, Canada
JV

Jeffrey T. Vietri, PhD

Director, HTA, Value, & Evidence
Pfizer, Inc.
Collegeville, PA, United States
Sr

Summer rosenstock, PhD, MHS

Pfizer Inc
Collegeville, Pennsylvania, United States
HL

Huihua Li, MS, MD

Director, Biostatistics
Pfizer, Inc
Collegeville, Pennsylvania, United States
AR

Alison E. Randall, MPH, PMP

Clinical Scientist
Pfizer, Inc.
New York, New York, United States
XZ

Xin Zhao, MS

Principal Scientist, Biostatistics
Genesis Research Group
Hoboken, New Jersey, United States
WZ

Wencheng Zhu, n/a

Genesis Research Group
Hoboken, New Jersey, United States
BZ

Bobby Zhao, PhD

Genesis Research Group
Hoboken, New Jersey, United States
AZ

Anan Zhou, MPH

Genesis Research Group
Hoboken, New Jersey, United States
CT

Christian Theilacker, MD, DTM&H

Pfizer Inc.
New York, New York, United States
JM

Jennifer Moisi, PhD

Pfizer Vaccines
Collegeville, Pennsylvania, United States
LJ

Luis Jodar, PhD

Chief Scientific Officer
Pfizer Vaccines
Collegeville, Pennsylvania, United States
PP

Paul Palmer, PhD

Doctor
Pfizer Vaccine Medical Development, Scientific & Clinical Affairs , Collegeville PA
Collegeville, PA, United States
AC

Alejandro D. Cane, MD, PhD

North America Vaccines Medical Scientific Affairs Lead
Pfizer
Collegeville, Pennsylvania, United States
PP

Paula Peyrani, MD

Senior Director
Pfizer, Inc
Collegeville, PA, United States